TRTC TRTC Opinions 11/02/2014 04:30:24

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
TRTC
TRTC Opinions 11/02/2014 04:30:24 $TRTC
TRTC
Regarding Monday's pps (statistical analysis)

.658 <==> Mean or Average
.54625 <==> Median
.47, .56 <==> Mode (tied)
1.295 <==> Midrange

* 11/2 26 entries
MONDAY PRICE PREDICTION CONTEST

Just put your name and guess below.
This is for the closing price.
Make sure to copy and paste the entire post including your guess, just like you did for the 6 Licenses Prediction Contest.
There will be no prize in this contest aside from bragging rights and kingship/queenship.

Dbrown13 .37
Lax .44 (without news) .49 with
hbstop .47
Paleti .47
NoleFan .48
White Lightning .495
jackagreene: .50
TDAWG .51
mx10001 .52
WtDoIknow .53
CBDpotential .533
Magnum7419 .54
labuyer .5425
pittski .55
Tomar .56
sj188 .56
Pot Penny .58
Dmcc .59
fatstaxx .62
StevenRisk .64
On2_addict .67
Widespread .68
sleek .73
LaughinPaulRyan .75
Doc K. 1.56
Bgrass1 2.22


I cannot believe this week is finally here.

DP is such a rockstar!

And Terra Tech is a megastock.

This week, we will all see a supernova of epic proportions.

I am proud of all you guys!

Sleek
Congrats to you Skoman!

TRTC is going to rock this week.

With the red fruits now confirming once again the accuracy of SLEEKVISION, this can only mean 1 thing:

DollarLand is in our very, very near future!

SleekBerry
TRTC up 45% in last 13 days....100% truth


3 permits in the bag and TRTC will get 6 out of 8 licenses.


maximus

MONDAY PRICE PREDICTION CONTEST

Just put your name and guess below.
This is for the closing price.
Make sure to copy and paste the entire post including your guess, just like you did for the 6 Licenses Prediction Contest.
There will be no prize in this contest aside from bragging rights and kingship/queenship.

Sleek .73
TDAWG .51
Dmcc .59
LaughinPaulRyan .75
StevenRisk .64
SJI888 .56
The RACE to Vegas. READ.
Read the article
AND the COMMENT.

http://www.thenug.com/galleries/the-race-to-v...bis-market


Analyst Positive on TRTC - Issues Analysis

TRTC Added as a Buy Recommendation
I asked privately, but you chose not to answer, so I'll put you on blast.........you used to be positive TRTC and could see what they were doing. So why have I seen nothing, but negative posts from you lately? I don't get what happened? Nothing has changed in their business model. Amy made a mistake, simple as that, and DP fixed it right away. That's all the bad that has happened in the entire timeline. You were a repected poster. You gained peoples, inluding mines, trust. Then you change your mind with no explanation? So I ask again, why did your opinion change? Please answer as I really am curious

HAIL!

TRTC$
Why are you even here bro. Why don't we all go over to the tw**d board and spin garbage.
Why do you give a shit?
Delusional! Hmmm compare rent costs
Looking forward to "you were wrong."
Wow definitions of facts are messed up
Cuckoo!!
Not bashing? Riiiight! Denial!
Twist and spin the information to try to take our focus off of TRTC and the 8 Nevada Licenses.

Nothing constructive to add....just argue about the irrelevant stuff....Ignore Options blocks their BS!

Next week the heat is on!!!!
Yup, they own the land and in turn the greenhouse built on it.
Ricky, CBD, DMCC,
Makes me wonder why DOC went long on TRTC on a weekend.I know he did not buy in today.

All of a sudden this dbrown shows up giving us the same BS the DOC was giving us.

dbrown sounds a lot like DOC or lpr to me.

JMHO.
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 10/30/2014 4:50:28 PM
Inergetics' Scientific/Medical Advisory Board to Meet as Company Enters Final Development Phase of New CBD Product Line "PR Newswire (US)" - 10/21/2014 9:00:00 AM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 10/6/2014 4:07:08 PM
Inergetics Discovers Unique Combination of Cannabinoids for New Product Line as it Exits Phase II of R&D and Prepares for Fin... "PR Newswire (US)" - 9/24/2014 10:00:00 AM
Why Vaporin, Inc Should be Trading at $15 "InvestorsHub NewsWire" - 9/22/2014 9:55:31 AM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 9/12/2014 4:55:21 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 9/9/2014 4:21:59 PM
As E-Cigs Begin to Take a Back Seat to Vaporizers, the Market looks for a Leader to Emerge "InvestorsHub NewsWire" - 8/25/2014 8:38:03 AM
VAPO Analyst Report; Good Old Common Sense Business Strategy Seems to be Working in This New Electronic Cigarette Industry "InvestorsHub NewsWire" - 8/15/2014 11:41:15 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/13/2014 4:10:04 PM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 8/13/2014 4:07:08 PM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 8/8/2014 5:34:25 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/6/2014 4:13:08 PM
Inergetics Enters Second Phase of a Three Phase Process to Launch its CBD-Based Supplements "PR Newswire (US)" - 8/5/2014 10:00:00 AM
Edible Garden(tm) Now Available at A&P Throughout the Northeast "GlobeNewswire Inc." - 7/31/2014 10:56:27 AM
Edible Garden(tm) Now Available at Kroger "GlobeNewswire Inc." - 7/30/2014 7:45:00 AM
Inergetics Completes Phase I Development of its Therapeutic CBD Line of Products "PR Newswire (US)" - 7/29/2014 10:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/25/2014 6:49:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/25/2014 6:46:52 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 7/24/2014 4:18:18 PM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 7/24/2014 4:15:43 PM
Terra Tech Corp Subsidiary, MediFarm, Submits Application for Medical Marijuana Dispensary in Las Vegas "GlobeNewswire Inc." - 7/24/2014 9:05:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/14/2014 2:30:43 PM
[img]http://investorshangout.com/images/stocks/logo2-TRTC
TRTC 11/02/2014 04:30:24-7-62-0-12-fff-8012014[/img]
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

SKK Holdings Limited Announces Pricing for Share IPO Offering

Updated Category News Views 65

SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...

Continue Reading
Antelope Enterprise: Financial Performance Insights for 2024

Updated Category News Views 149

Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...

Continue Reading
Olivier Falut Steps Into CFO Role at EUROAPI to Drive Growth

Updated Category News Views 344

Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...

Continue Reading
OPEXUS and Casepoint Join Forces for Growth and Innovation

Updated Category News Views 261

OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...

Continue Reading
MeiraGTx Holdings: An In-Depth Look at Future Potential

Updated Category News Views 69

MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...

Continue Reading